Three PE/VC firms lead financing for AI-driven drug company

SoftBank Vision Fund 2, PICC Capital and Morningside co-led a $318 million financing of XtalPi, an artificial intelligence-based drug discovery and development company based in Massachusetts and . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.